RN7SL338P

Across TCGA pan-cancer cohorts, RN7SL338P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RN7SL338P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL338P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL338P expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

HNSC, BLCA, and DLBC are the cancer types where RN7SL338P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	All	0.578	0.324	<.001	104	view →
BLCA	OS	Quartile	III,IV	0.219	0.533	.002	56	view →
DLBC	DFS	Tertile	All	0.442	0.935	<.001	54	view →
LUAD	DFS	Median	All	0.844	0.749	.001	51	view →
MESO	DFS	Tertile	II,III,IV	0.130	0.504	.017	27	view →
UVM	OS	Tertile	III,IV	0.452	0.933	.003	18	view →
THCA	OS	Tertile	II,III,IV	0.953	0.985	.017	13	view →
STAD	DFS	Median	All	0.601	0.801	.008	12	view →
LUSC	DFS	Quartile	All	0.279	0.443	.009	12	view →
BRCA	DFS	Tertile	III,IV	0.878	0.747	.016	11	view →
LAML	DFS	Median	All	0.554	0.247	.008	10	view →
PRAD	OS	Quartile	All	0.753	0.919	.006	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RN7SL338P–HNSC (OS)

Open the HNSC breakdown →